next-generation sequencing

Dxome is a CLIA-certified, CAP-accredited clinical laboratory leveraging advanced genomic technologies to deliver actionable genetic insights that empower healthcare providers to personalize treatments and improve patient care. The laboratory combines cutting-edge genomic technologies with rigorous quality control processes to deliver accurate, reliable molecular testing.

Clinical genomicsmolecular diagnosticspharmacogenomicsSpatial multiomics

ElevateBio is an advanced therapies CDMO that partners with innovators to identify drug targets and manufacture clinical and commercial cell and gene therapy products. Its capabilities span discovery, gene editing design and optimization, process development, technology transfer, analytical development, next-generation sequencing, cGMP manufacturing, regulatory CMC, and quality, across modalities including cell therapies, viral vectors, mRNA therapeutics and vaccines, and gene editing.

analytical developmentautomationcGMP manufacturinggene editing design & optimizationgenerative AIprocess developmentqualityregulatory CMCtechnology transfer

Encompass Diagnostics is a CLIA-certified high-complexity molecular testing laboratory with over 10 years of experience in real-time QPCR technologies. It provides molecular pathogen testing, pharmacogenetics, and other specialty molecular testing, delivering results within 24-48 hours, and also offers high-capacity COVID-19 testing for individuals and workplace environments nationwide.

antibiotic resistance gene detectionCLIA high-complexity molecular testingcytopathologyDNA extractionFISHFlow Cytometryhistopathologyimmunohistochemistrymass spectrometrymoderate complexity clinical testingmolecular pathologymolecular PCR testingpharmacogeneticsreal-time QPCR

Endura Therapeutics is an RNA covalency company developing small molecule drugs that form a permanent covalent bond with mRNA, blocking translation and knocking down disease-causing proteins. The company pioneers chemo-genomics, combining Enduring Chemistry with next-generation sequencing to quantify binding in cells at single-nucleotide resolution through its TRANSCEND platform. It targets diseases that can't be treated at the protein level, including cancers such as STAT3 and SMARCA2/4 lung cancer, and neurodegeneration from repeat expansions. Based in

chemo-genomicscovalent chemistryRNA-targeting small molecule drug discovery

Epoch Life Science, Inc. is a biotech company headquartered in Fort Bend County, Texas, described as a direct spin-off from the Texas Medical Center. It develops and commercializes reagents for the isolation, expression, analysis, and purification of genes and their protein products, and offers molecular biology services. Products are sold through a direct sales team, an e-commerce website, and a worldwide distributor network.

codon optimizationcustom cloninggene synthesisnucleic acid purificationpeptide synthesisplasmid preparationprotein expression and optimizationSanger DNA sequencingsite-directed mutagenesis

Eviogen Discovery is an innovation-driven Contract Research Organization (CRO) established in 2016, offering integrated drug discovery services and customized bio solutions to pharma, biotech, life-science industries and research organizations. It provides services from target discovery to lead candidate selection, including target ID and validation, hit-to-lead, lead optimization, and in-vitro safety and toxicology studies, with flexible FFS or FTE business models.

assay biologyFlow Cytometryhigh content imagingin vitro ADMEin vivo PKmedicinal chemistryprotein expression and purificationqPCRscreeningSPR (Biacore)stable cell line generation

Evolve Genomix is a genomics company making genomic technologies accessible for agriculture, food safety, and public health. It offers rapid diagnostics and high-throughput sequencing, including rapid field-use test kits and targeted metagenomics, and is an NSF SBIR Phase I grant winner for rapid pathogen detection technology.

assay and device developmentBioinformaticshigh-throughput sequencingmicrobial genome sequencingqPCRrapid diagnosticstargeted metagenomics

Foundation Medicine is a global, patient-focused precision medicine company delivering high-quality, transformative diagnostic solutions in cancer and other diseases. Founded in 2010, it developed one of the first standardized comprehensive genomic profiling (CGP) platforms using next-generation sequencing to analyze a broad panel of genes and detect all four classes of genomic alterations. It provides tests and solutions across the patient experience, from diagnosis to treatment selection to ongoing monitoring, and partners with biopharmaceutical compan

AI-enabled toolsassay validationcompanion diagnostic developmentcomprehensive genomic profiling (CGP)IHC testing

Genohub is a one-stop shop and marketplace for next-generation sequencing (NGS) and bioinformatics services, connecting researchers and clinicians with a curated network of over 100 partnering service providers. Genohub offers free scientific consultation, quality and turnaround time guarantees, and secure online project management tools for tracking projects, accepting quotes, and sharing files.

bioinformatics data analysisdata transfer and storagelibrary preparationoptical genome mappingOxford Nanopore sequencingproject management

Hemato Logics, Inc. is a diagnostic service laboratory established in 1995 that provides immunophenotyping, cytogenetics, fluorescence in situ hybridization, molecular analysis studies, next-generation sequencing, and its own ∆N:™ (Difference from Normal) Flow Cytometry. It is described as the recognized leader for Measurable Residual Disease testing for Acute Leukemia and performs all testing in-house.

aCGH/SNP microarraycell enrichmentcell sortingcytogeneticsFISHFlow Cytometryimmunophenotypingmolecular analysisPCRSanger sequencing

Illumina applies innovative sequencing and array technologies to the analysis of genetic variation and function, serving life science research, translational and consumer genomics, and molecular diagnostics. The company describes its mission as improving human health by unlocking the power of the genome, offering next-generation sequencing and microarray solutions from benchtop to production scale, along with bioinformatics software and support.

bioinformatics and data analysisin vitro diagnostic testinglibrary preparationmethylation profilingmicroarray genotypingsingle-cell RNA-Seq